DGAP-Adhoc
HAEMATO AG proposes dividend payment
DGAP-Ad-hoc: HAEMATO AG / Key word(s): Dividend/Payout Ad hoc of HAEMATO AG: |
HAEMATO AG proposes dividend payment
The Supervisory Board of HAEMATO AG approved the Executive Board's proposal for the appropriation of profits at today's balance sheet meeting. The Executive Board and Supervisory Board will therefore propose a dividend of EUR 1.00 per dividend-bearing share at the Annual General Meeting to be held on July 13, 2021.
About HAEMATO:
HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of its business activities is on the trading of high-priced special pharmaceuticals (with a therapeutic focus on cancer, HIV and other chronic diseases) as well as the development and distribution of medical products and own brands, particularly in the field of "aesthetic medicine".
HAEMATO AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange.
Key figures of the HAEMATO AG share:
Subscribed capital: EUR 5,299,307
Listed share class: Ordinary bearer shares
ISIN: DE000A289VV1
WKN: A289VV
Stock exchange symbol: HAEK
Contact:
HAEMATO AG, Investor Relations
Telefon: +49 (0)30 897 30 86 70
ir@haemato.ag
04-May-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: | English |
Company: | HAEMATO AG |
Lilienthalstraße 5c | |
12529 Schönefeld | |
Germany | |
Phone: | +49 (0)30 897 30 86 70 |
Fax: | +49 (0)30 897 30 86 79 |
E-mail: | ir@haemato.ag |
Internet: | www.haemato.ag |
ISIN: | DE000A289VV1 |
WKN: | A289VV |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Stuttgart, Tradegate Exchange |
EQS News ID: | 1192406 |
End of Announcement | DGAP News Service |
|
1192406 04-May-2021 CET/CEST